Biguanides
Showing 1 - 25 of 76
Stroke, Ischemic, Mild Cognitive Impairment, Dementia, Vascular Trial in León (Dapagliflozin 10mg Tab, Statins (Cardiovascular
Recruiting
- Stroke, Ischemic
- +3 more
- Dapagliflozin 10mg Tab
- +3 more
-
León, Guanajuato, MexicoHospital General de Zona IMSS 21
Oct 3, 2022
Glycemic Patterns After Bariatric Surgery and High Glycemic
Recruiting
- Bariatric Surgery
- Glucose monitoring with flash glucose monitor
-
Rio De Janeiro, BrazilLaboratory for Clinical and Experimental Research on Vascular Bi
Feb 11, 2023
Abdominal Obesity, Type 2 Diabetes Trial in San Luis Potosi (Biguanide, DPP4 inhibitors, SGLT2 inhibitors)
Enrolling by invitation
- Abdominal Obesity
- Type 2 Diabetes
- Biguanide, DPP4 inhibitors, SGLT2 inhibitors
-
San Luis Potosi, MexicoMetabolic Research Unit
Sep 1, 2021
A Pan-European Post-Authorisation Safety Study: Risk of
Not yet recruiting
- Pancreatic Cancer
- Exenatide
- Non-GLP-1 RA based glucose lowering drugs
- (no location specified)
Dec 21, 2022
Renal Insufficiency, Chronic Trial in Mansoura, Tanta (Metformin, Empagliflozin, Standard therapy)
Recruiting
- Renal Insufficiency, Chronic
- Metformin
- +2 more
-
Mansoura, Dakahlia Governorate, Egypt
- +1 more
May 12, 2022
Irreversible Pulpitis Trial in Karachi (Polyhexamethylene biguanide, Sodium Hypochlorite)
Not yet recruiting
- Irreversible Pulpitis
- Polyhexamethylene biguanide
- Sodium Hypochlorite
-
Karachi, Sindh, PakistanHira Danish
Mar 29, 2022
Acute Ischemic Stroke, Basilar Artery Occlusion Trial in Beijing (Best medical management, Endovascular treatment)
Recruiting
- Acute Ischemic Stroke
- Basilar Artery Occlusion
- Best medical management
- Endovascular treatment
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Oct 20, 2023
Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Japan (Dulaglutide, Biguanide (BG), Sulfonylurea (SU))
Active, not recruiting
- Diabetes Mellitus
- +6 more
- Dulaglutide
- +6 more
-
Nagoya-shi, Aichi, Japan
- +43 more
Jan 16, 2023
Obesity and Bariatric Surgery According toBiopsychosocial
Recruiting
- Obesity
- +4 more
- Holter Faros 360° EKG (Bittium Corporation)
- +4 more
-
Rio De Janeiro, Rio De Janeiro, Brazil, BrazilLaboratory for Clinical and Experimental Research on Vascular Bi
Jul 10, 2023
Diabetic Peripheral Neuropathy Trial in Jedda (Group- A (100% weight-bearing; n=14), (moderate-intensity (50-70% heart rate
Completed
- Diabetic Peripheral Neuropathy
- Group- A (100% weight-bearing; n=14), (moderate-intensity (50-70% heart rate reserve) aerobic exercise training on the antigravity treadmill, 3 times/week for 12-weeks.
- +4 more
-
Jedda, Saudi ArabiaUmm Al-Qura University
Sep 29, 2022
Irisin And Diabetic Nephropathy
Not yet recruiting
- Irisin
- Laboratory tests
- +5 more
- (no location specified)
Nov 20, 2021
Diabetes, Type 2 Trial in Jinan (behavioral, drug, other)
Recruiting
- Diabetes Mellitus, Type 2
- Lifestyle therapy
- +3 more
-
Jinan, Shandong, China
- +1 more
Jul 5, 2021
Erythroplakia, Oral Leukoplakia Trial in Canada, United States (Extended Release Metformin Hydrochloride, Placebo
Not yet recruiting
- Erythroplakia
- Oral Leukoplakia
- Biopsy
- +3 more
-
Tucson, Arizona
- +9 more
Dec 14, 2022
PreDiabetes Trial in Leon (Black bean protein hydrolysates (BPH), Commercial non-caloric beverage)
Completed
- PreDiabetes
- Black bean protein hydrolysates (BPH)
- Commercial non-caloric beverage
-
Leon, Guanajuato, MexicoUniversidad de Guanajuato
May 19, 2023
Ulcerative Colitis, IBD Trial in Tanta (metformin 500 mg TID Oral Tablet, Placebo)
Unknown status
- Ulcerative Colitis
- Inflammatory Bowel Diseases
- metformin 500 mg TID Oral Tablet
- Placebo
-
Tanta, الغربية, EgyptTanta University Hospitals
Feb 7, 2021
Diabetes Complications, Periodontal Diseases Trial (Front view photography of the patient's oral cavity with the help of a
Not yet recruiting
- Diabetes Complications
- Periodontal Diseases
- Front view photography of the patient's oral cavity with the help of a smartphone in the diabetology department.
- (no location specified)
May 25, 2023
Atherosclerosis, Diabetes, Restenosis Trial in Stockholm (Bydureon, Humulin kwickpen, Metformin)
Recruiting
- Atherosclerosis
- +2 more
- Bydureon
- +2 more
-
Stockholm, Other, SwedenDept of clinical science and education Karolinska Institutet Söd
Aug 31, 2021
Prostate Cancer Trial in Toronto (Metformin, Atorvastatin, Placebo (corresponding to metformin))
Withdrawn
- Prostate Cancer
- Metformin
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 16, 2021
Effect of Change in T1DM Glycemic Control Trial in Cairo (metformin, Basal/bolus insulin)
Completed
- Effect of Change in T1DM Glycemic Control
- metformin
- Basal/bolus insulin
-
Cairo, EgyptNancy Elbarbary
May 6, 2021
Impaired Glucose Tolerance, Insulin Sensitivity, Glucose Metabolism Disorders Trial in Oslo (Metformin capsule 500 mg,
Recruiting
- Impaired Glucose Tolerance
- +2 more
- Metformin capsule 500 mg, Empagliflozin encapsulated tablet 10 mg, Pioglitazone encapsulated tablet 30 mg, Linagliptin encapsulated tablet 5 mg
-
Oslo, NorwayOslo University Hospital, Aker Hospital
Apr 5, 2021
Acanthamoeba Keratitis Trial in Italy, Poland, United Kingdom (PHMB 0.08%, Propamidine 0.1%, )
Unknown status
- Acanthamoeba Keratitis
- PHMB 0.08%
- +3 more
-
Milano, Italy
- +5 more
Oct 22, 2020
Nonalcoholic Fatty Liver Disease, NAFLD, Nonalcoholic Steatohepatitis Trial in London (Rifaximin)
Terminated
- Nonalcoholic Fatty Liver Disease
- +2 more
-
London, United KingdomLiver Unit, St Mary's Hospital, Imperial College London
Oct 5, 2020
Diabetic Neuropathies Trial in Islamabad (SLP, SLP along with Physiotherapy, Physiotherapy)
Recruiting
- Diabetic Neuropathies
- SLP
- +2 more
-
Islamabad, Federal, PakistanPakistan Railway Hospital
Mar 21, 2021